Real-World Evidence

Real-World and Actionable Data for Healthcare

Partnering with Alira Health

Alira Health provides diverse expertise spanning the value chain of real-world evidence. As our partner, you’ll benefit from our:

  • Strong analytics experience in the French claims database (SNDS/Health Data Hub)
  • In-house strategic data consultancy, medico-economics methodologists, data engineers, data scientists, and visualization experts
  • Established partnerships in data management and technological solutions
  • A patient-centric e-Health platform that offers technology solutions in clinical research and digital therapeutics, powered by bepatient, an Alira Health company. Request a demo here
  • GDPR compliance by design

Improving patient care through data

Alira Health serves healthcare practitioners, institutions, research labs, CROs, pharma, and the device industry to leverage and interpret data across the entire healthcare ecosystem.

Working together to humanize healthcare

Whether you need to understand which asset best aligns with your long-term strategy, which new market or therapeutic area to explore, or how to expand into another sector, we are ready to help you lead the way.

Contact us
Romain Finas
Romain Finas
Vice President, Real-World Evidence
Our combination of health economists, biostatisticians, and IT experts provide accessible, actionable evidence from hospitals, insurance companies, and patient devices.

Related News

Events August 10, 2022
DPHARM
We are pleased to announce that we will be sponsoring and attending DPHARM, a unique event focused on the latest innovations that modernize clinical trials.
Clinical Decentralized Clinical Trials DPHARM Patient Centric
Publications August 4, 2022
White Paper: New European Health Technology Assessment Regulation
In this white paper, we provide an overview of this new regulation, including key points of the new European Health Technology Assessment Regulation, its methodology, and its timelines.
MedTech Regulatory
Publications August 2, 2022
GMP Manufacturing and IND-Enabling Studies of a Recombinant Hyperimmune Globulin Targeting SARS-CoV-2
The last two years have brought forward tremendous advances in the development of prophylactic and therapeutic approaches for the treatment of SARS-CoV-2 infections.
Clinical CMC Vaccines
Multimedia August 1, 2022
Partners in the Continuum of Drug Development
Listen to the new Empowered Patient Podcast with Karen Jagoda as Gabriele Brambilla, Alira Health CEO, discusses novel approach using technology services to actively engage and partner(...)
Decentralized Clinical Trials Digital Health Patient Centric
Multimedia July 20, 2022
The Promise and Reality of NGTs
Listen to the episode “The Promise and Reality of Next Generation Therapies".
Market Access
Publications July 15, 2022
How to leverage registry-based studies to generate high-quality Real-World Evidence
The use of Real-World Evidence (RWE) in regulatory decision making will support the development and application of better medicines.
Real-World Evidence Registry-based studies Regulatory RWE
Publications July 14, 2022
How to successfully use the EMA IRIS portal to ensure timely submissions
Submitting your scientific advice (SA), orphan drug designation (ODD) or Innovation Task Force (ITF) consultation to the EMA? Avoid delays with our submission recommendations.
European Medicines Agency Orphan Drug Regulatory
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.